Disease-modifying activity of ruxolitinib in a patient with <i>JAK2</i>-negative CMML-2Silvan Francke, Uwe Platzbecker, Manja Meggendorfer et al.|Leukemia & lymphoma/Leukemia and lymphoma|2016Cited by 5